Veru Stock News

Veru stock collapsed Thursday after the FDA's advisors voted against the company's cancer drug turned Covid treatment. The post Veru Stock Plummets 65% After FDA Advisors Vote Down Cancer-Turned-Covid

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 66.5% to settle at $29.10 on Monday amid recent reports suggesting Donald Trump could announce a 2024 presidential run this week.

Veru Inc. (VERU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r

U.S. stocks closed higher on Monday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording gains in the previous session. Digital World Acquisition Corp. (NAS

Veru Inc. (VERU) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday. The Dow traded up 1.24% to 32,804.26 while the NASDAQ rose 0.67% to 10,545.27. The S&P 500

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870. Veru Inc. (NASDAQ: VERU) shares jumped 47% to $15.22 following publication of briefing documents ahead of the Nov.

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday. The Dow traded up 0.68% to 32,621.97 while the NASDAQ rose 0.14% to 10,490.21. The S&P 500

Investors are reacting positively to an FDA briefing document.

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.18% to 32,461.54 while the NASDAQ fell 0.25% to 10,

Pharmaceutical firm Veru (NASDAQ: VERU ) kicked off the first complete week of November with a bang as it delivered overall positive results regarding its Covid-19 therapeutic sabizabulin. Targeting t

Veru stock skyrocketed Monday after the Food and Drug Administration posted a mixed review of its repurposed cancer drug for Covid treatment. The post Medical Leader Veru Catapults As FDA Preps To Dis

Investors are reacting positively to an FDA briefing document.

Sector ETF report for PTH

MIAMI, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncolo